- Trials with a EudraCT protocol (94)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
94 result(s) found for: Pulmonary Emphysema.
Displaying page 1 of 5.
EudraCT Number: 2015-004110-23 | Sponsor Protocol Number: GTi1201-OLE | Start Date*: 2016-03-29 | |||||||||||
Sponsor Name:Grifols Therapeutics LLC | |||||||||||||
Full Title: An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alphal-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Al... | |||||||||||||
Medical condition: Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) EE (Ongoing) PL (Ongoing) FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002525-23 | Sponsor Protocol Number: NB19751C | Start Date*: 2007-02-22 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A double-blind, placebo-controlled efficacy (as assessed by post-bronchodilator FEV1) and safety study of 5 mg RO3300074 once-daily for 2 years in subjects with smoking-related, moderate-to-severe... | |||||||||||||
Medical condition: symptomatic smoking-related emphysema in ex-smokers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) IS (Completed) LV (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001870-38 | Sponsor Protocol Number: GTi1201 | Start Date*: 2014-01-09 | |||||||||||
Sponsor Name:Grifols Therapeutics Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alphal-Proteinase Inhibitor (Human) in Sub... | |||||||||||||
Medical condition: Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) IE (Completed) EE (Completed) DK (Ongoing) ES (Completed) FI (Restarted) PL (Ongoing) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004869-18 | Sponsor Protocol Number: 030547 | Start Date*: 2008-07-03 | ||||||||||||||||||||||||||
Sponsor Name:UHB NHS Foundation Trust | ||||||||||||||||||||||||||||
Full Title: Evaluation of the relative severity of pulmonary neutrophilic inflammation and therapeutic modification with IV Prolastin by means of 18 FDG PET/CT scanning in subjects with alpha1-antitrypsin defi... | ||||||||||||||||||||||||||||
Medical condition: The medical condition is emphysema and will be investigated in subjects with alpha 1-antitrypsin deficiency. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017872-26 | Sponsor Protocol Number: 1147/09 | Start Date*: 2010-02-22 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Role and pharmacological modulation of lug inflammation in chronic obstructive pulmonary disease (COPD) | |||||||||||||
Medical condition: chronic obstructive pulmonary disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001853-15 | Sponsor Protocol Number: NL61830 | Start Date*: 2018-07-11 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: An explorative study for halting inflammation in patients with emphysema by intravenous administration of autologous bone marrow derived mesenchymal stromal cells. | ||
Medical condition: Pulmonary emphysema | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003459-12 | Sponsor Protocol Number: CE1226_4001 | Start Date*: 2006-01-30 | |||||||||||
Sponsor Name:CSL Behring GmbH | |||||||||||||
Full Title: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase III/IV Study to compare the Efficacy and Safety of 60 mg/kg body weight of Zemaira® weekly i.v. administration with Placebo weekly ... | |||||||||||||
Medical condition: Chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) DE (Completed) FI (Completed) EE (Completed) SE (Completed) CZ (Completed) DK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002563-23 | Sponsor Protocol Number: CD-RI-MEDI8968-1103 | Start Date*: 2012-03-15 | |||||||||||
Sponsor Name:MedImmune Limited | |||||||||||||
Full Title: A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) LV (Completed) CZ (Completed) LT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000053-21 | Sponsor Protocol Number: FLUI-2014-134 | Start Date*: 2015-05-05 | |||||||||||
Sponsor Name:FLUIDDA nv | |||||||||||||
Full Title: Placebo controlled study to assess the effect of Roflumilast in hyperinflated COPD patients in addition to LABA/LAMA therapy using Functional Respiratory Imaging. | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007129-38 | Sponsor Protocol Number: CE1226_3001 | Start Date*: 2008-03-14 | |||||||||||
Sponsor Name:CSL Behring GmbH | |||||||||||||
Full Title: An open-label, non-controlled, multicenter, multinational Study to evaluate the Efficacy and Safety of Zemaira® administration in Chronic Augmentation and Maintenance Therapy in Subjects with Emphy... | |||||||||||||
Medical condition: Chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) CZ (Completed) DE (Completed) FI (Completed) SE (Completed) EE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012231-15 | Sponsor Protocol Number: ML22608 | Start Date*: 2009-11-10 | |||||||||||
Sponsor Name:Roche Pharma AG | |||||||||||||
Full Title: Pharmacokinetics of Mycophenolate Mofetil in de novo lung allograft recipients | |||||||||||||
Medical condition: Prevention of acute allograft rejections in de novo lung allograft recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002389-29 | Sponsor Protocol Number: PULSE-COPD-007 | Start Date*: 2016-07-25 | ||||||||||||||||||||||||||
Sponsor Name:Bellerophon Pulse Technologies, LLC | ||||||||||||||||||||||||||||
Full Title: An Exploratory Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on Functional Respiratory Imaging (FRI) Parameters in Subjects with World Health Organization (WHO) Group 3 ... | ||||||||||||||||||||||||||||
Medical condition: Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001749-42 | Sponsor Protocol Number: 484/12 | Start Date*: 2012-08-07 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on lung inflammation in COPD. | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003106-27 | Sponsor Protocol Number: RLV116974 | Start Date*: 2012-11-01 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared with Fluticasone Propionate/Salmeterol ... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001743-36 | Sponsor Protocol Number: PT003018-00 | Start Date*: 2015-12-01 | |||||||||||
Sponsor Name:Pearl Therapeutics, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Single-Center Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volu... | |||||||||||||
Medical condition: Moderate to severe Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-005005-43 | Sponsor Protocol Number: FACEII | Start Date*: 2022-06-06 | |||||||||||
Sponsor Name:Consorci Mar Parc de Salut de Barcelona | |||||||||||||
Full Title: Ferinject in Addition to pulmonary rehabilitation in patients with COPD and iron deficiency to improve Exercise tolerance (FACE II study) | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010669-22 | Sponsor Protocol Number: 1237.6 | Start Date*: 2011-09-19 | |||||||||||
Sponsor Name: [...] | |||||||||||||
Full Title: A randomised, double-blind, parallel group study to assess the efficacy and safety of 52 weeks of once daily treatment of orally inhaled tiotropium plus olodaterol fixed dose combination (2.5 μg / ... | |||||||||||||
Medical condition: Patients with Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) SE (Completed) ES (Completed) SK (Completed) BE (Completed) DE (Completed) HU (Completed) IE (Completed) AT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002466-39 | Sponsor Protocol Number: MVD-PROT-001 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Morphine or Fentanyl for Refractory dyspnea in COPD | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease, COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003931-12 | Sponsor Protocol Number: BXU513667 | Start Date*: 2017-12-13 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: A Randomized Controlled Non-inferiority Study to Evaluate the Efficacy and Safety of Hemopatch Compared to TachoSil in Preventing or Reducing Postoperative Air Leaks After Pulmonary Resection. | |||||||||||||
Medical condition: Postoperative air leakage. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004179-38 | Sponsor Protocol Number: PULMORA | Start Date*: 2020-01-10 | |||||||||||
Sponsor Name:Västra Götalandsregionen | |||||||||||||
Full Title: Effects of tofacitinib vs methotrexate on clinical and molecular disease activity markers in joints and lungs in early rheumatoid arthritis | |||||||||||||
Medical condition: Patients with early active rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.